Does nutraceutical N-111 lower the number of side effects occurring during ADT + External Beam Radiation (EBR) prostate cancer treatment?
Researchers will compare nutraceutical N-111 to a placebo (a look-alike substance that contains no active ingredients) and control group to see if N-111 works to alleviate side effects of prostate cancer treatment. Participants will: Take N-111 or a placebo by mouth every day for the duration of the ADT + EBR therapy. Fill out the self-evaluation reporting form weekly during EBR therapy and every three months during ADT therapy to assess their symptoms or lack of symptoms. The patients will see a physician once a week during the EBR therapy and once every three months for the duration of the ADT therapy.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Enrollment
100
Optimal Health Research
Salt Lake City, Utah, United States
Self-reporting
Self-reporting symptom severity and number of symptoms. The scoring is from 1 (no issue) to 10 (severe), across 14 questions.
Time frame: Weekly for the duration of EBR (6 weeks). Monthly for the duration of ADT (2 years).
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.